CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 5,421,147
- Share change
- -28,454
- Total reported value
- $38,274,000
- Price per share
- $7.06
- Number of holders
- 30
- Value change
- -$194,328
- Number of buys
- 8
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC |
13F
|
Company |
7.4%
|
1,109,167
|
$7,764,000 | — | 30 Jun 2017 | |
| ARIEL INVESTMENTS, LLC |
13F
|
Company |
6.5%
|
976,377
|
$6,835,000 | — | 30 Jun 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5.7%
|
866,283
|
$6,125,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
400,445
|
$2,803,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
298,635
|
$2,111,000 | — | 30 Jun 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
293,700
|
$2,076,000 | — | 30 Jun 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.9%
|
290,853
|
$2,036,000 | — | 30 Jun 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
1.8%
|
269,377
|
$1,904,000 | — | 30 Jun 2017 | |
| JW Asset Management, LLC |
13F
|
Company |
1.8%
|
263,881
|
$1,847,000 | — | 30 Jun 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.86%
|
130,073
|
$911,000 | — | 30 Jun 2017 | |
| BARD ASSOCIATES INC |
13F
|
Company |
0.59%
|
88,515
|
$620,000 | — | 30 Jun 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.47%
|
71,354
|
$500,000 | — | 30 Jun 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.36%
|
53,800
|
$380,000 | — | 30 Jun 2017 | |
| EAGLE GLOBAL ADVISORS LLC |
13F
|
Company |
0.35%
|
52,767
|
$369,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
48,610
|
$343,000 | — | 30 Jun 2017 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.24%
|
36,626
|
$259,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
25,726
|
$180,000 | — | 30 Jun 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.16%
|
23,892
|
$167,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.14%
|
21,018
|
$147,000 | — | 30 Jun 2017 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.14%
|
20,896
|
$146,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
20,338
|
$142,000 | — | 30 Jun 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.13%
|
20,300
|
$142,000 | — | 30 Jun 2017 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.11%
|
15,959
|
$112,000 | — | 30 Jun 2017 | |
| DELTA ASSET MANAGEMENT LLC/TN |
13F
|
Company |
0.08%
|
12,000
|
$84,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
10,830
|
$75,000 | — | 30 Jun 2017 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.07%
|
10,000
|
$70,000 | — | 30 Jun 2017 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
5,198
|
$37,000 | — | 30 Jun 2017 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.03%
|
3,851
|
$27,000 | — | 30 Jun 2017 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
3,130
|
$22,000 | — | 30 Jun 2017 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$21,000 | — | 30 Jun 2017 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.01%
|
1,186
|
$8,000 | — | 30 Jun 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,022
|
$7,000 | — | 30 Jun 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
740
|
$5,000 | — | 30 Jun 2017 | |
| MUFG Americas Holdings Corp |
13F
|
Company |
0%
|
230
|
$2,000 | — | 30 Jun 2017 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q3 2017
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.